At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
Inset II with Lantern Technologydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Longevity of Multi-Slitted Catheter, the Convatec Inset II With Lantern Technology
In Brief
A clinical study evaluating Inset II with Lantern Technology for Insulin Dependent Diabetes Mellitus 1. Completed, enrolled 24 participants across 1 site.
Detailed Summary
To determine time to set failure when the Convatec Inset II with Lantern technology (Convatec Lantern) infusion set with multi-slitted catheter is worn for up to 10 days
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsulin Dependent Diabetes Mellitus 1
CountriesUnited States
CollaboratorsConvaTec Inc.
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJan 2019
First PostedJan 2019
Primary CompletionApr 2019
TodayJul 2026
First PostedJan 28, 2019
Enrollment StartJan 25, 2019
Primary CompletionApr 20, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.4 years ago
Interventions
Inset II with Lantern Technologydevice
Each participant will insert the Inset II with Lantern technology and wear it for 10 days or until set failure and data will be collected on the cause of set failure. The infusion set will be used with their usual insulin pump.